[18] Therefore, the available human evidence does not establish clinically meaningful efficacy for obesity
The FDA's concerns cite peptide manufacturing risks: incompletely characterised active ingredient, peptide fragments, degradation products, and impurities that the immune system may recognise as foreign
Stress, dietary factors, and absorption challenges can all contribute to depleted levels, leading to fatigue, brain fog, and low motivation
Studies have explored its potential in models of ulceration, inflammatory bowel disease analogues, and intestinal fistulas
Its 15-amino-acid sequence and stability profile make it one of the most widely referenced compounds in peptide research environments studying recovery and repair mechanisms
Pernicious anemia and autoimmune gastritis are different stages, and indeed different aspects, of the same disease continuum